Psyence Biomedical Ltd. Common Shares (PBM) — Long-term Investment Intensity
Psyence Biomedical Ltd. Common Shares (PBM) has a Long-term Investment Intensity of 40.4% as of September 2025. Long-term investments of $5.17 Million represent 40.4% of total assets of $12.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PBM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Psyence Biomedical Ltd. Common Shares Long-term Investment Intensity (2025–2025)
This chart shows how Psyence Biomedical Ltd. Common Shares's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of September 2025, the intensity stands at 40.4%, reflecting long-term investments of $5.17 Million against total assets of $12.81 Million USD. Explore how well can Psyence Biomedical Ltd. Common Shares service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Psyence Biomedical Ltd. Common Shares (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Psyence Biomedical Ltd. Common Shares from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Psyence Biomedical Ltd. Common Shares market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 10.2% | $745.00K | $7.32 Million | — |